OPTIONS FOR MANAGING PSYCHOTROPIC MEDICATIONS IN DRUG-ABUSING PATIENTS PARTICIPATING IN BEHAVIORAL THERAPIES CLINICAL TRIALS
Saved in:
ROUNSAVILLE, B.J., ET AL., OPTIONS FOR MANAGING PSYCHOTROPIC MEDICATIONS IN DRUG-ABUSING PATIENTS PARTICIPATING IN BEHAVIORAL THERAPIES CLINICAL TRIALS. AMERICAN JOURNAL ON ADDICTIONS, Vol. 8, no. 3 (1999), p. 178-189.
Ref.
79250
Location:
SIIS R.1264 Archivo
Palabras clave:
Drogodependencias, Experimentación, Fármacos, Terapia, Tratamiento
Drogodependencias, Experimentación, Fármacos, Terapia, Tratamiento
Similar Items: OPTIONS FOR MANAGING PSYCHOTROPIC MEDICATIONS IN DRUG-ABUSING PATIENTS PARTICIPATING IN BEHAVIORAL THERAPIES CLINICAL TRIALS
- "RESEARCH" VERSUS "REAL-WORLD" PATIENTS: REPRESENTATIVENESS OF PARTICIPANTS IN CLINICAL TRIALS OF TREATMENTS FOR COCAINE DEPENDENCE
- PROTECTION OF PARTICIPANTS AND EXPERIMENTAL DESIGN IN CLINICAL ABUSE LIABILITY TESTING
- THE ETHICAL CONDUCT OF CLINICAL TRIALS OF HIV VACCINES
- NATURALISTIC FOLLOW-UP OF DRINKING BEHAVIOR FOLLOWING PARTICIPATION IN AN ALCOHOL ADMINISTRATION STUDY
- STAFF BELIEFS ABOUT DRUG ABUSE CLINICAL TRIALS
- RETRACING THE STEPS OF MARCO POLO: FROM CLINICAL TRIALS TO DIFFUSION ON INTERVENTIONS FOR SMOKERS